At ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) from July 27-31 in Chicago, laboratory medicine experts will communicate the awe-inspiring power of this field to advance healthcare and transform lives around the globe. Presented this year in partnership with the Canadian Society of Clinical Chemists (CSCC), the meeting will delve into a variety of timely topics, including urgent problems related to clinical AI integration, fake medical news, and the pervasiveness of plastics, as well as tapping into the promise of genomics and microbiome medicine for personalized healthcare.

A University of Cincinnati College of Medicine researcher has been awarded a $2.6 million federal grant to study a potentially deadly form of heart disease that affects people with diabetes called diabetic cardiomyopathy.

The aging liver undergoes dramatic changes in its functional organization and other key attributes, which may underpin its increasing susceptibility to disease, according to a study led by investigators at Weill Cornell Medicine. The findings suggest the possibility of future therapies that would block or reduce such changes to treat or prevent age-related chronic liver diseases—effectively making the liver more youthful and resilient.

In the past year, suspected non-fatal overdoses from opioids increased 39% in Connecticut, based on emergency room admissions data. A new study drawing from this data has identified several key risk factors associated with non-fatal overdoses, as well as a significantly higher overdose rate. The findings of this study highlight not only the need to increase the number of people able to access treatment, but also the need to address factors like mental health challenges in these settings.